Seroepidemiological studies have shown that approximately 60% of adults in developed countries and up to 100% of adults in developing countries are positive for antibodies against HCMV. 5 BMT ...
SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results